NT
Neonc Technologies Holdings, Inc.
NTHI · NASDAQ
$3.33 +1.52% (+$0.05)
1M -29.00%
Market Cap $86.4M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 25.98%
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
57 /100
Average ROIC 229.42%
Asset turnover 0.00x
ROA 902.18%
Debt
0 /100
High Current ratio 0.14x
Int. coverage -12.99x
Debt/Equity N/A
Stability
19 /100
Unstable Beta 0.50x
Profitable years 0
Rev. volatility 159.34%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NTHI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Amir Farrokh Heshmatpour
Employees
5
Headquarters
Calabasas
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report